HomeDXCM • NASDAQ
add
DexCom Inc
Previous close
$65.08
Day range
$62.86 - $71.34
Year range
$54.11 - $93.25
Market cap
27.31B USD
Avg Volume
5.76M
P/E ratio
39.59
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.26B | 13.12% |
Operating expense | 469.70M | 0.60% |
Net income | 267.30M | 76.20% |
Net profit margin | 21.22 | 55.80% |
Earnings per share | 0.68 | 51.11% |
EBITDA | 386.60M | 56.71% |
Effective tax rate | 21.54% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.00B | -22.51% |
Total assets | 6.34B | -2.23% |
Total liabilities | 3.59B | -17.98% |
Total equity | 2.75B | — |
Shares outstanding | 384.80M | — |
Price to book | 9.11 | — |
Return on assets | 11.67% | — |
Return on capital | 17.21% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 267.30M | 76.20% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Dexcom, Inc. is an American healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland. Wikipedia
Founded
1999
Headquarters
Website
Employees
10,250
